Home › NDC Lookup › Ingredients › Simethicone › 00904-7206-60
⚪image loading
(from DailyMed)

Antiflatulent Simethicone 80 mg Tablet, Chewable, 100-count — NDC 0904-7206-60 (Billing 00904-7206-60)

by Major Pharmaceuticals · 100 TABLET, CHEWABLE in 1 BOTTLE

This is a package of 100 tablets of Antiflatulent Simethicone 80 mg Tablet, Chewable from Major Pharmaceuticals, marketed since Oct 2021 and currently FDA-listed; retail pharmacies pay about $0.0322 per tablet (NADAC). It is this product's only package size.

NDC 00904-7206-60
🏷️ FDA NDC (as labeled) 0904-7206-60 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0904-7206-60 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0904 labeler · 7206 product · 60 package
Package marketed since
Oct 4, 2021
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
100 EA per package
Barcode (UPC)
0309047206605
Medicaid fills, this package
81,639 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0904-7206-60
Product NDC 0904-7206
11-digit billing NDC 00904720660
NCPDP billing unit EA — each (per item)
RxCUI 314216
UNII 92RU3N3Y1O
UPC 0309047206605
Application # M002
SPL Set ID d321114e-09ac-4252-a6e6-3dbc3a451ee6
Physiologic effect Skin Barrier Activity
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-10-04
Route ORAL
Dosage form TABLET, CHEWABLE
Substance DIMETHICONE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 52200020000510
GPI class Simethicone
GCN Seq No 002821
GCN 08281
HICL code 001224
Ingredient (HICL) Simethicone
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D4
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Alimentary Tract
HIC3 code D4N
Therapeutic class — specific (HIC3) Antiflatulents
AHFS code 56:10.00.00
AHFS class Antiflatulents
FDB label name SIMETHICONE 80 MG TAB CHEW
FDB brand name Simethicone
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 002821
  • GCN: 08281
  • GPI-14 (Medi-Span): 52200020000510
  • HICL (First Databank): 001224
  • AHFS class code: 56:10.00.00
  • RxCUI (RxNorm): 314216
Why two NDCs? The FDA registers this code as 0904-7206-60 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00904-7206-60. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name SIMETHICONE 80 MG TAB CHEW Ingredient Simethicone
📗 Our plain-language guide HelloPharmacist
  • It relieves the discomfort of gas. For adults, that means pressure, bloating and fullness. Infant drops are for baby gas, often caused by swallowed air or certain formulas or foods...
  • Shake the bottle well. Use only the syringe or dropper that came with it. Dispense it slowly toward the inner cheek. You can also mix it with 1 oz. of cool water, formula or anothe...
  • Doses can be repeated as needed after meals and at bedtime. Do not go over 12 doses in a day. Follow your product’s label and your doctor’s advice.
  • If you can, use your child’s weight. If not, use age. Check the chart on your product, and ask me or your doctor if you are unsure.
📖 Read our full Simethicone guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.032 $3.22 / 100 tablets
Medicaid paysCMS SDUD · 12 mo $0.1258 $12.58 / 100 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jun 2022 Dec 2023 Mar 2026 Sep 2026 $0.037 $0.027
▲ Up 16% over the last 19 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00904-7206-60 You're viewing this Main listing 100 TABLET, CHEWABLE in 1 BOTTLE 2021-10-04 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Antiflatulent 80 mgthis 00904-7206-60 Major 100 tablets $0.032 — Availability likely —
GNP Regular Strength Gas Relief 80 mg 24385-0118-78 Amerisource 100 tablets $0.032 — Availability likely —
Leader Gas relief 80 mg 70000-0434-01 CARDINAL 100 tablets $0.032 — Availability likely —
Gas Relief 80 mg 70677-1067-01 STRATEGIC 36 tablets $0.032 — Availability likely —
Gas Relief 80 mg 17714-0019-01 Advance 100 tablets — — FDA listed —
GNP Regular Strength Gas Relief 80 mg 17856-1118-01 ATLANTIC 1 tablet — — FDA listed —
CVS PHARMACY Gas relief 80 mg 51316-0111-00 CVS 100 tablets — — FDA listed —
Gas relief Anti-gas 80 mg 51316-0904-16 CVS 100 tablets — — FDA listed —
Gas relief 80 mg 53041-0103-16 Guardian 100 tablets — — FDA listed —
Gas relief 80 mg 53943-0301-16 Discount 100 tablets — — FDA listed —
Simethicone 80 mg 54738-0518-01 Richmond 100 tablets — — FDA listed —
Simethicone 80Mg 80 mg 55154-2606-00 Cardinal 1 tablet — — FDA listed —
Simethicone 80 mg 57896-0791-01 Geri-Care 100 tablets — — FDA listed —
QC Gas Relief Mint Flavor 80 mg 63868-0108-01 QUALITY 100 tablets — — FDA listed —
Simethicone 80 mg 68071-2746-03 NuCare 30 tablets — — FDA listed —
Gas Relief Mint Flavor 80 mg 68163-0111-36 Raritan 36 tablets — — FDA listed —
Simethicone 80 mg 69618-0033-01 Reliable 100 tablets — — FDA listed —
Simethicone 80 mg 71610-0607-04 Aphena 4 tablets — — FDA listed —
Simethicone 80 mg 71610-0649-04 Aphena 4 tablets — — FDA listed —
Antiflatulent 80 mg 71610-0650-04 Aphena 4 tablets — — FDA listed —
Simethicone 80Mg 80 mg 77333-0812-10 Gendose 1 tablet — — FDA listed —
Simethicone 80 mg 82804-0043-30 Proficient 30 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Oct 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII IY9XDZ35W2
    Dextrose is a simple sugar derived from corn or other sources. It serves as a filler and sweetener in medicines to add bulk, improve taste, and help stabilize the medication's form.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 7CVR7L4A2D
    A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 506T60A25R
    Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.
  • UNII 81H2R5AOH3
    A natural sweetener and carbohydrate derived from sugarcane plants. In medicines, it sweetens the taste to improve palatability and may serve as a bulking agent or binder in tablets and powders.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescompressible sugar, dextrose, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sorbitol.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMajor Pharmaceuticals
FDA applicationM002 (OTC MONOGRAPH DRUG)
Labeler code00904
First marketedOct 2021
Product typeHuman Otc Drug
Portfolio630 products on file

More NDCs from Major Pharmaceuticals labeler code 00904

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 9 words ▾

USE(S) relieves: pressure bloating symptoms referred to as gas

⏱️ Dosage and Administration 26 words ▾

DIRECTIONS chew 2 to 4 tablets thoroughly as needed after meals and at bedtime do not exceed 6 tablets per day unless directed by a physician

⚠️ Warnings 2 words ▾

WARNINGS .

📦 Storage and Handling 27 words ▾

OTHER INFORMATION do not use if inner seal is broken store at room temperature avoid high humidity and excessive heat, above 40 o C (104 o F)

🧪 Active Ingredient 7 words ▾

ACTIVE INGREDIENT(in each tablet) Simethicone 80 mg

🧪 Inactive Ingredients 12 words ▾

INACTIVE INGREDIENTS compressible sugar, dextrose, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sorbitol.

🎯 Purpose 2 words ▾

PURPOSE Antigas

📄 Keep Out of Reach of Children 21 words ▾

KEEP OUT OF REACH OF CHILDREN In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.

📄 Questions or Comments 4 words ▾

QUESTIONS Call (800) 616-2471

📄 Package Label / Principal Display Panel 20 words ▾

PRINCIPAL DISPLAY PANEL NDC 0904-7206-60 MAJOR Simethicone Simethicone 80 mg antiflatulent relieves: gas pain pressure bloating 100 Chewable Tablets 3-103-100-maj-o.jpg

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
81.6K
Units reimbursed last 4 qtrs
5.3M
Gross reimbursed last 4 qtrs
$669.8K
Avg / prescription
$8.20
Avg / unit
$0.1258
Latest quarter Q4 2025
20.1KRx
Medicaid pays / ea
$0.1258
gross reimbursed
vs
NADAC / ea
$0.0322
acquisition cost
=
Spread
+$0.0936
+291% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
54% FFS 46% MCO
Fee-for-service · 43,746 Rx Managed care · 37,893 Rx
State Medicaid map
Alaska: no data reported AK Maine: 35,801 units · 2,566 per 100k residents ME Washington: 270,938 units · 3,468 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 274,150 units · 4,779 per 100k residents MN Wisconsin: 3,178 units · 53.8 per 100k residents WI Michigan: 303,682 units · 3,026 per 100k residents MI New York: 942,454 units · 4,816 per 100k residents NY Vermont: 15,895 units · 2,457 per 100k residents VT New Hampshire: 10,849 units · 774 per 100k residents NH Oregon: 84,791 units · 2,003 per 100k residents OR Nevada: 18,287 units · 573 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 66,097 units · 527 per 100k residents IL Indiana: 42,973 units · 626 per 100k residents IN Ohio: 371,908 units · 3,156 per 100k residents OH Pennsylvania: 357,342 units · 2,757 per 100k residents PA New Jersey: 154,639 units · 1,665 per 100k residents NJ Massachusetts: 216,668 units · 3,095 per 100k residents MA California: 1,363,561 units · 3,499 per 100k residents CA Utah: 596 units · 17.4 per 100k residents UT Colorado: no data reported CO Nebraska: 88,417 units · 4,470 per 100k residents NE Missouri: no data reported MO Kentucky: 166,872 units · 3,687 per 100k residents KY West Virginia: no data reported WV Virginia: 85,816 units · 985 per 100k residents VA Maryland: 36,537 units · 591 per 100k residents MD Connecticut: no data reported CT Rhode Island: 19,038 units · 1,739 per 100k residents RI Arizona: 114,097 units · 1,535 per 100k residents AZ New Mexico: 1,384 units · 65.5 per 100k residents NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 23,926 units · 445 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 5,034 units · 45.6 per 100k residents GA D.C.: 5,632 units · 829 per 100k residents DC Hawaii: 22,471 units · 1,566 per 100k residents HI Texas: 219,644 units · 720 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
17.44,816
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 4,816 /100k
2 Minnesota 4,779 /100k
3 Nebraska 4,470 /100k
4 Kentucky 3,687 /100k
5 California 3,499 /100k
6 Washington 3,468 /100k
7 Ohio 3,156 /100k
8 Massachusetts 3,095 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
← 00904-7205-46 · Major 00904-7208-06 · Major →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.